Last reviewed · How we verify
NCT04455672
A Comparative Study Using Two 3D Printed Occlusal Splints for Patients With Tempromandibular Disorder
NA trial testing splints in Temporomandibular Disorder in 24 participants. Status unknown.
26 July 2021
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 1 July 2020 |
| Primary completion | 26 July 2021 |
| Estimated completion | 26 September 2021 |
Drugs / interventions tested
- splints
Conditions studied
- Temporomandibular Disorder — all drugs for Temporomandibular Disorder →
Sponsor
Cairo University
Who can join
Adults 20 to 50, male only, with Temporomandibular Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
• to compare the relief of pain for patients with anterior disc displacement with reduction between two groups; in the first group a digitally formed stabilizing splint followed by an anterior repositioning splint (ARS) and the second group a digitally fabricated (ARS) splints followed by a stabilizing splints
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
3D-Printed anterior repositioning splint versus stabilization splint for patients with anterior disc displacement with reduction: A randomized cross-over clinical trial.
Tahoon MMS, Abdelnabi NM, Elsisy AME, Moussa ARA, et al · · 2025 · cited 1× · PMID 40213888 · DOI 10.4103/jips.jips_8_25
Verify or expand the search:
- PubMed search for NCT04455672
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Temporomandibular Disorder
Currently open trials in the same condition.
- NCT06941636 — Botulinumtoxin A as a Treatment for Myalgia and Myofacial Pain in Patient With Temporomandibulardisorders · Phase 3 · recruiting
- NCT03849534 — Treatment of Temporomandibular Disorders in Children and Adolsecents · NA · recruiting
- NCT06214923 — Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG) · NA · recruiting
- NCT06365151 — An Algorithm for Approaching Temporomandibular Disorders With Osteopathic Manual Therapy in Patients With Fibromyalgia · NA · recruiting
- NCT06357702 — K23- Physical Self Regulation vs Placebo · NA · recruiting
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04455672 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 2 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04455672.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing